Tamiflu, Relenza Data Show Little Clinical Benefit Against Flu (FREE)

By Joe Elia The neuraminidase inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza) have only marginal benefits in the treatment and prevention of influenza, a series of BMJ articles concludes.Investigators reviewed documents submitted to regulatory agencies concerning both drugs.Tamiflu data showed …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news

Related Links:

Publication date: Available online 8 October 2020Source: Microbes and InfectionAuthor(s): Keisuke Nishioka, Michihito Kyo, Takaaki Nakaya, Nobuaki Shime
Source: Microbes and Infection - Category: Infectious Diseases Source Type: research
ConclusionsPatients on various solid tumour treatments achieve sero-protection rate congruent with the general population. The sero-protection HIA titres were not sustained at 24  weeks postvaccination.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
Comparison of deaths from the coronavirus (COVID-19) with deaths from influenza (flu) and pneumonia. Includes deaths by date of death occurrence and breakdowns by sex and age.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
CONCLUSIONS: Promoting asthma self-management education, influenza vaccinations, nebulizers, and spacers can decrease the frequency of healthcare utilization and asthma-related expenditures while improving medication adherence. PMID: 33031709 [PubMed - as supplied by publisher]
Source: Journal of Asthma - Category: Respiratory Medicine Tags: J Asthma Source Type: research
CONCLUSIONS: Our results underscore how erroneous reporting of 1 condition can lead to underreporting of other causes of death. Misapplication or misunderstanding of procedures by medical providers, rather than extrinsic factors influencing the reporting process, are key drivers of erroneous cause-of-death reporting. PMID: 33031711 [PubMed - as supplied by publisher]
Source: Public Health Reports - Category: International Medicine & Public Health Tags: Public Health Rep Source Type: research
Publication date: Available online 7 October 2020Source: The Annals of Thoracic SurgeryAuthor(s): Rony Atoui, Fady Ebrahim F, Kevin Saroka, John Mireau, Janet E. McElhaney, Gregory Hare
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Since its emergence the impact of COVID-19 has been profound, and the public health challenge seem to be the most serious seen in a respiratory virus since the 1918 H1N1 influenza pandemic (Soper 1919). Following its emergence in Wuhan, cases of COVID-19 were exported outside of China, mainly by travelers using the global aviation networks (Wu et al., 2020). It should be noted that transboundary spread of viruses is quite common in veterinary medicine (Klausner et al., 2015, 2017, 2018).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
Source: MayoClinic.com - Ask a Specialist - Category: Consumer Health News Source Type: news
The COVID-19 pandemic exerts inflammation-related parasympathetic complications and post-infection manifestations with major inter-individual variability. To seek the corresponding transcriptomic origins for the impact of COVID-19 infection and its aftermath consequences, we sought the relevance of long and short non-coding RNAs (ncRNAs) for susceptibility to COVID-19 infection. We selected inflammation-prone men and women of diverse ages among the cohort of Genome Tissue expression (GTEx) by mining RNA-seq datasets from their lung, and blood tissues, followed by quantitative qRT-PCR, bioinformatics-based network analyses ...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Publication date: Available online 7 October 2020Source: American Journal of Infection ControlAuthor(s): Peng-jun Lu, Anup Srivastav, Tammy A. Santibanez, Ashley Amaya, Jill A. Dever, Jessica Roycroft, Marshica Stanley Kurtz, Walter W. Williams
Source: American Journal of Infection Control - Category: Infectious Diseases Source Type: research
More News: Influenza | Oseltamivir | Primary Care | Relenza | Tamiflu | Zanamivir